Does BRODALUMAB Cause Hepatocellular carcinoma? 8 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hepatocellular carcinoma have been filed in association with BRODALUMAB (Siliq). This represents 0.4% of all adverse event reports for BRODALUMAB.
8
Reports of Hepatocellular carcinoma with BRODALUMAB
0.4%
of all BRODALUMAB reports
3
Deaths
5
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From BRODALUMAB?
Of the 8 reports, 3 (37.5%) resulted in death, 5 (62.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BRODALUMAB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does BRODALUMAB Cause?
Psoriasis (418)
Drug ineffective (177)
Arthralgia (175)
Fatigue (152)
Psoriatic arthropathy (141)
Intentional product use issue (136)
Headache (126)
Therapy interrupted (126)
Product dose omission issue (124)
Disease recurrence (118)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which BRODALUMAB Alternatives Have Lower Hepatocellular carcinoma Risk?
BRODALUMAB vs BROLUCIZUMAB
BRODALUMAB vs BROLUCIZUMAB-DBLL
BRODALUMAB vs BROMAZEPAM
BRODALUMAB vs BROMFENAC
BRODALUMAB vs BROMHEXINE